Chewable tablets made by a North Kansas City company are being pulled from shelves across the country after tests found they packed more punch than the label promised.
Shaman Botanicals, based in North Kansas City, says it is voluntarily recalling one lot of its Alkaloids Chewable Tablets White Vein after discovering the product contains higher-than-labeled levels of a potent alkaloid. The affected lot, B# AAW.501.3, was shipped to retailers and sold online nationwide. The company warns that the tablets contain more than 7-hydroxymitragynine (7-OH) than the labeled 7.5 milligrams per tablet, which could leave users taking a much larger dose than they realize and increase the risk of adverse effects.
What Was Recalled
According to the U.S. Food and Drug Administration, the agency posted Shaman Botanicals' recall notice on February 17 after recent testing confirmed the White Vein chewables exceeded the declared 7.5 milligrams of 7-OH per tablet. The recall covers Lot B# AAW.501.3 sold in two-count and 20-count bags and in a 30-count bottle, with UPCs 810057763724, 810057763830, and 810057763779. The FDA notice includes product photos and step-by-step guidance on where to find the lot number on the packaging.
Where It Was Sold And How To Return
So far, Shaman Botanicals says it has not received reports of adverse events tied to the recalled lot. The company is notifying distributors and customers by email, arranging product returns and offering either refunds or replacement products, according to Daily Voice. Consumers who have the product are urged to stop using it immediately, quarantine any bottles or bags that match the recalled lot number, and register a return through the company's recall portal. Shaman Botanicals has also provided a quality-department phone line at 855-427-7386 and an email address for customers with questions.
Why 7-OH Raises Red Flags
Health officials and reporters have been sounding the alarm about 7-hydroxymitragynine because high concentrations can produce opioid-like effects and carry risks of overdose and dependence. Federal agents seized tens of thousands of 7-OH products from Kansas City-area warehouses linked to the manufacturer late last year, according to a Justice Department statement. Investigative reporting by the Kansas City Star has also tracked the compound's spread through smoke shops, gas stations and online retailers. Those enforcement moves followed earlier federal warnings about products that add or concentrate 7-OH for use in dietary supplements.
What To Watch For And How To Report
Anyone who has already taken tablets from the recalled lot and feels unwell is advised to contact a physician right away and seek emergency medical care if symptoms are severe. The recall notice also urges consumers to report any adverse events to the FDA's MedWatch program and to follow the company's return instructions posted on the agency's recall page, which includes the full recall portal link and all listed contact details.
Legal And Regulatory Fallout
The recall is landing in the middle of a broader legal and regulatory fight over 7-OH products. Plaintiffs have filed a class-action complaint alleging the product's marketing and distribution caused consumer harm, and federal enforcement actions have targeted inventory and distribution links to the firm, as reported by the Justice Department. Regulators continue to weigh additional enforcement steps while companies pull affected lots off the market.
Shoppers who bought Advanced Alkaloids chewables are being urged to check their packages for Lot B# AAW.501.3 and follow the manufacturer's return instructions. The recall is a blunt reminder that high-potency alkaloid products sold outside regulated pharmaceutical channels can come with serious, sometimes hidden, risks.
